Patent · US Active

Substituted nucleosides, nucleotides and analogs thereof

US11021509B2 · kind B2 · utility

1Cited by
97References
25Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 31, 2019
Grant dateJun 1, 2021
Priority date
Expiry dateJul 31, 2039

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12Y207/07048
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Disclosed herein are nucleosides, nucleotides and analogs thereof, pharmaceutical compositions that include one or more of nucleosides, nucleotides and analogs thereof, and methods of synthesizing the same. Also disclosed herein are methods of ameliorating and/or treating a disease and/or a condition, including an infection from a paramyxovirus and/or an orthomyxovirus, with a nucleoside, a nucleotide and an analog thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.